Healthcare & Life Sciences Private Equity Deal Tracker: The Vistria Group Invests in Medalogix and Muse Healthcare

McGuireWoods LLP
Contact

The Vistria Group has announced the recapitalization and a growth investment in Medalogix and Muse Healthcare.

Medalogix, based in Nashville, Tenn., is a data science company focused exclusively on home health and hospice.

Muse Healthcare, based in Shoreview, Minn., is a data science company that provides analytics designed to support hospice patient transitions.

Medalogix and Muse Healthcare will consolidate under the Medalogix brand. In addition, three home health and hospice entities are coming on board as minority equity investors: LHC Group, Amedisys Home Health and Hospice and Encompass Health Corp. Combined, the minority investors provide home health or hospice care across 45 states.

The Vistria Group, based in Chicago, focuses on making investments in middle market companies in healthcare and a few other industries. Founded in 2013, the firm pursues control and minority equity investments and prefers to make more substantial investments from a dollars perspective in companies with at least $100 million in revenue.

Terms of the investments were not disclosed.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
Contact
more
less

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.